Nasdaq-listed Quantum BioPharma R&D Focused Business, Developing Solutions and Treatments
Jan 30, 2025
18:45
forum Ask episode
view_agenda Chapters
auto_awesome Transcript
info_circle Episode notes
Quantum BioPharma is developing a portfolio of products including Quantum's Lucid-MS drug development and their drink, unbuzzd. In this episode, Adam Torres and Jason Sawyer, Head of Finance & M&A at Quantum BioPharma, explore Quantum BioPharma.